Invention Publication
- Patent Title: CDK INHIBITORS
-
Application No.: US17922804Application Date: 2021-05-04
-
Publication No.: US20230174512A1Publication Date: 2023-06-08
- Inventor: Zhilong Hu , Hu He , Fei Zhang , Wenge Zhong , Xiaotian Zhu
- Applicant: QILU REGOR THERAPEUTICS INC.
- Applicant Address: CN Shanghai
- Assignee: QILU REGOR THERAPEUTICS INC.
- Current Assignee: QILU REGOR THERAPEUTICS INC.
- Current Assignee Address: CN Shanghai
- Priority: CN TCN2020088585 2020.05.05
- International Application: PCT/US2021/030728 2021.05.04
- Date entered country: 2022-11-02
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K45/06 ; A61P35/00
Abstract:
The invention provides a compound represented by the following structural formula: (I) or a pharmaceutically acceptable salt, or a stereoisomer thereof useful for treating cancer.
Public/Granted literature
- US12285429B2 CDK inhibitors Public/Granted day:2025-04-29
Information query
